SaniSure, a global developer and manufacturer of single-use technology for the biopharmaceutical industry, announced today it has acquired GL Engineering (GLE) of East Hanover, New Jersey.

SaniSure, a global developer and manufacturer of single-use technology for the biopharmaceutical industry, announced today it has acquired GL Engineering (GLE) of East Hanover, New Jersey.
AllCells, the industry leader in the procurement and customization of human-derived hematological tissues and services, is pleased to announce the expansion of its flagship processing facility in Alameda, California.
Amcor Unveils State-of-the-art Healthcare Packaging Facility In Singapore To Serve Accelerating Customer Demands In Asia Pacific
3M and Ford are collaborating on specific ways the companies can rapidly combine complementary capabilities and resources to help meet a surge in demand for personal protective equipment due to the COVID-19 outbreak.
Hygiene expert Christeyns expands its activities in the Life Science Division with the acquisition of Pliwa, German producer of disinfection products for hospitals and dental care. Although negotiated and signed before the corona crisis, the transaction – which was closed last Friday – will allow Christeyns to increase its production capacity of disinfectants for medical applications. As such the company hopes to provide even better support to the medical sector in these challenging times.
Medivant Health is currently building a 33,000-square-foot generic drug manufacturing facility in Chandler, Arizona. The first phase will create 10,000 square feet of manufacturing and laboratory space able to produce 40,000 vials of generic drug products every day. Medivant is a new Current Good Manufacturing Practice (CGMP) Manufacturer. Medivant is unique in that its sole purpose is to fill this generic drug shortage void. The facility is fully automated with minimal human intervention.
Comar Acquires iMARK Molding Comar, a premier plastic packaging, dispensing, and medical device provider serving the...
GISTs arise from specialized nerve cells found in the walls of the gastrointestinal tract. One or more mutations in the DNA of one of these cells may lead to the development of GIST.
FDA takes efforts to improve quality of compounded drugs from outsourcing facilities through collaboration and education as part of new Center of Excellence. Compounded drugs can serve an important role in meeting patients’ medical needs that cannot be met by an FDA-approved drug.
Millstone Medical Outsourcing has officially broken ground on its new 56,385 square foot facility in Fall River, MA. The MA headquarter campus will now hold a total of 124,367 square feet of production space, including its existing 15,000 square feet of class 10,000/ISO7-rated cleanroom space for medical device packaging operations.
Pepscan announced that its GMP production capacity has doubled. Pepscan is an all-in-one partner in peptides, building on 25 years of experience in advancing and applying peptide expertise to facilitate clients in the development and production of peptides.
GE Healthcare Life Sciences and Germfree are joining expertise to develop a fully integrated, expandable manufacturing solution for emerging biotherapeutics, including gene therapy.